|
FBXO34 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.916400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.666990E-01 |
| Normal-vs-Stage2 |
5.496800E-01 |
| Normal-vs-Stage3 |
9.476000E-01 |
| Normal-vs-Stage4 |
6.816400E-02 |
| Stage1-vs-Stage2 |
9.322600E-01 |
| Stage1-vs-Stage3 |
3.748600E-01 |
| Stage1-vs-Stage4 |
2.531000E-01 |
| Stage2-vs-Stage3 |
6.161000E-01 |
| Stage2-vs-Stage4 |
3.209200E-01 |
| Stage3-vs-Stage4 |
1.842000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.831400E-01 |
| Normal-vs-AfricanAmerican |
5.027600E-01 |
| Normal-vs-Asian |
6.733400E-01 |
| Caucasian-vs-AfricanAmerican |
9.514000E-01 |
| Caucasian-vs-Asian |
8.569800E-01 |
| AfricanAmerican-vs-Asian |
8.594400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.630000E-01 |
| Normal-vs-Female |
3.506600E-01 |
| Male-vs-Female |
7.330800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.713000E-01 |
| Normal-vs-Extreme_Weight |
1.084760E-01 |
| Normal-vs-Obese |
6.694400E-01 |
| Normal-vs-Extreme_Obese |
7.850800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.666600E-01 |
| Normal_Weight-vs-Obese |
4.902200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.379000E-01 |
| Extreme_Weight-vs-Obese |
3.488400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.606000E-01 |
| Obese-vs-Extreme_Obese |
9.558200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.474000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.927200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.719900E-02 |
| Normal-vs-Age(81-100Yrs) |
7.390000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.164800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.219200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.211800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.629700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.661600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.490200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.459600E-01 |
| Normal-VS-Type2 PRCC |
4.336800E-01 |
| Normal-VS-KIRP CIMP |
5.621800E-04 |
| Normal-VS-Unclassified PRCC |
9.677800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.171200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.036200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.398200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.016210E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.723600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.612080E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.291750E-02 |
| Normal-vs-N1 |
6.813400E-01 |
| Normal-vs-N2 |
2.38889999999436E-05 |
| N0-vs-N1 |
1.193040E-01 |
| N0-vs-N2 |
2.806000E-02 |
| N1-vs-N2 |
1.582780E-04 |
|
|
